Dompé Farmaceutici and Omega Pharma announced the agreement for the international marketing of the OTC product range of the Italian biopharmaceutical group. Omega Pharma is a division of Perrigo Company and has been granted the exclusive right to distribute the main brands of the OTC line of the Italian group in over 50 countries. The first marketing activities are expected in 2017 and should cover key countries in Europe. The strategy of incremental innovation implemented by Dompé Group in the OTC area combines the expertise acquired by Omega Pharma, a global company aimed at offering a wide range of high-quality therapeutic solutions to patients in North America, Europe and Australia.